In the Evaluate Renal Function With Semaglutide Once Weekly (FLOW) trial, Glucagon-like peptide-1 receptor agonists (GLP-1Ras) reduced the risk of major kidney disease events by approximately 20%24% and slowed the annual rate of eGFR decline, suggesting potential value in targeting the metabolic-inflammatory axis for anti-renal fibrosis
While Zepbound does not directly cause hemorrhoids through its pharmacological mechanism, the medication's gastrointestinal side effects may create conditions that increase the risk of developing or exacerbating hemorrhoidal disease
This screening ensures baseline pancreatitis status is established before therapy initiation
Good weight loss plans help you achieve a healthy weight, BMI, hip-to-waist ratio, all of which improve your overall health
This guide covers the best Chick-fil-A orders for GLP-1 users, what to skip, and how to customize for your reduced appetite